StockData
Bioventus Inc. logo

Bioventus Inc. (BVS) stock

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.62+0.02 (+0.19%)

Close on Nov 18, 2026Market cap $893.06MP/E 13.8Yield –

Bioventus pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bioventus's pe ratio was 13.7× on Nov 11, 2026, against 69.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.7×−53.9
2025Dec 31, 202567.6×+39.4
2022Apr 29, 202228.2×–

More Bioventus figures

See a number that looks wrong?